Page 3 - Philipp Mathieu News Today

LUND, Sweden, Feb. 20, 2023 /PRNewswire/ -- Immunovia AB (publ), reg. no. 556730-4299, hereby gives notice that an Extraordinary General Meeting ("EGM") will take place on Thursday 16th March

/PRNewswire/ -- Immunovia will publish its full year 2022 results on February 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast...

NOT FOR PUBLICATION, RELEASE DISSEMINATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN...

LUND, Sweden, Feb. 8, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first test dedicated to the early detection of pancreatic

/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the worlds first test dedicated to the early detection of...

/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the worlds first blood test dedicated to the early detection...

The firm said it will reduce in-house R&D staff from its operations in Lund, Sweden, as it focuses on bringing the ImmRay PanCan-d test to the US market.

Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs to Accelerate Commercial strategy of IMMray™ PanCan-d test in the US market - read this article along with other careers information, tips and advice on BioSpace

LUND, Sweden, Jan. 17, 2023 /PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company that has launched the world's first blood test dedicated to the early detection of pancreatic

/PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company that has launched the worlds first blood test dedicated to the early detection...